Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
148.00
-0.10 (-0.07%)
At close: Jul 26, 2026

DSE:BXPHARMA Financials Overview

Millions BDT. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
53,92649,12044,39239,26734,66929,494
Revenue Growth
12.43%10.65%13.05%13.26%17.55%15.16%
Gross Profit
25,56922,04919,40317,10215,68113,816
Operating Income
11,3329,3878,2916,9026,5806,346
Net Income
8,6506,9415,8304,6145,1235,128
Earnings Per Share
19.3915.5613.0710.3411.4811.49
EPS Growth
28.90%19.06%26.34%-9.94%-0.09%45.89%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '24 Jun '23 Jun '22 Jun '21
Bangladesh
44,89941,28136,33431,88926,331
Export
4,0742,9582,7632,6853,124
Unallocated
147.73152.62169.2695.0438.39
Total
49,12044,39239,26734,66929,494

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
5,7842,7981,2231,3021,277788.3
Total Debt
3,1634,9666,02510,61212,3717,631
Net Cash (Debt)
2,621-2,168-4,802-9,310-11,094-6,843
Net Cash Growth
------
Net Cash Per Share
5.87-4.86-10.76-20.87-24.87-15.34

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
10,4687,2238,3646,0855,2146,023
Capital Expenditures
-3,225-2,781-1,994-2,411-2,815-2,521
Free Cash Flow
7,2424,4416,3713,6742,3993,503
Free Cash Flow Growth
130.26%-30.29%73.40%53.15%-31.51%6.17%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
47.42%44.89%43.71%43.55%45.23%46.84%
Operating Margin
21.01%19.11%18.68%17.58%18.98%21.52%
Pretax Margin
20.99%18.33%16.95%15.46%19.29%21.62%
Profit Margin
16.04%14.13%13.13%11.75%14.78%17.39%
FCF Margin
13.43%9.04%14.35%9.36%6.92%11.88%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Dividend Per Share
4.7504.7504.0003.5003.5003.500
Dividend Per Share Growth
0%18.75%14.29%0%0%156.67%
Dividend Yield
3.21%5.52%3.56%2.58%2.50%2.22%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
7.635.539.0414.1413.4615.43
Forward PE
7.626.788.6212.0810.8316.20
P/FCF Ratio
9.128.658.2717.7528.7522.58
PS Ratio
1.220.781.191.661.992.68